What is MLYS's current stock price?

MLYS (Mineralys Therapeutics, Inc.) is currently trading at $29.85 with a market cap of $1.98B.

What sector is Mineralys Therapeutics, Inc. in?

Mineralys Therapeutics, Inc. (MLYS) operates in the Healthcare sector, specifically in the Biotechnology industry.

Is MLYS a good stock to buy?

Analysts have a Buy consensus on MLYS with a price target of $46.00. Check our detailed analysis for valuation, financials, and insider activity.

InvestLog

MLYS Mineralys Therapeutics, Inc.

Healthcare

$29.85-1.26%ClosedMarket Cap: $1.98B

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

3.87

P/S

0.00

EV/EBITDA

-11.16

DCF Value

$2.53

FCF Yield

-6.9%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

-27.9%

ROA

-23.2%

ROIC

-26.9%

Financials

View All

Period	Revenue	Net Income	EPS
Q1 null	$0.00	$-39.3M	$—
Q4 null	$0.00	$-32.2M	$—
FY null	$0.00	$-154.7M	$—
Q3 null	$0.00	$-36.9M	$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$46.00

Target (Median)

$52.00

Target Range

$30.00 - $56.00

0 Strong Buy9 Buy1 Hold0 Sell0 Strong Sell

B of A SecuritiesBuy

2026-03-13

StifelBuy

2025-12-19

HC Wainwright & Co.Buy

2025-11-12

Wells FargoOverweight

2025-11-11

Wells FargoOverweight

2025-09-11